elucidated that m6A methylation enhanced the levels of NUTM2B-AS1 by stabilizing its transcript, and the m6A-modified NUTM2B-AS1 facilitated hepatocellular carcinoma cell proliferation and stemness by epigenetically upregulating BMPR1A expression (47). This evidence concerns the gene NUTM2B and hepatocellular carcinoma.